(Q37622898)

21 August 2017

1 reference

title

Update on vaccination guidelines for allergic children (English)

1 reference

21 August 2017

John M Kelso

1

1 reference

21 August 2017

publication date

1 November 2009

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

11

1 reference

21 August 2017

page(s)

1541-1546

1 reference

The prevalence of atopic dermatitis in Oregon schoolchildren

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Risk of Anaphylaxis After Vaccination of Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

An algorithm for treatment of patients with hypersensitivity reactions after vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

IgE-mediated systemic reactions to gelatin included in the varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Safe administration of the measles vaccine to children allergic to eggs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Safe administration of influenza vaccine to patients with egg allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Current issues with influenza vaccination in egg allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Anaphylaxis after hepatitis B vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Live attenuated versus inactivated influenza vaccine in infants and young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Immunologic influences on allergy and the TH1/TH2 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

No epidemiological evidence for infant vaccinations to cause allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.09.107

21 January 2018

Identifiers

DOI

10.1586/ERV.09.107

1 reference

21 August 2017

1 reference